Advertisement

Topics

Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Company Profile

05:24 EDT 22nd September 2018 | BioPortfolio

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company focused on the development and commercialization of miRNA therapeutics. The Company has a foundational intellectual property portfolio on the therapeutic use of miRNAs developed by its own scientists as well as in-licensed from other institutions. Mirna’s IP portfolio contains more than 300 miRNAs with applications in oncology and other diseases. Oncology-directed miRNAs include those that are key tumor suppressors in cancer, such as miR-34 and let-7, which have been shown to block tumor growth in a number of different preclinical animal studies. The Company, founded in 2007 and located in Austin, Texas, has received significant funding from Sofinnova Ventures, New Enterprise Associates, Pfizer Venture Investments and other private investors, as well as the State of Texas, both through the State’s Emerging Technology Fund and from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, visit www.mirnarx.com.


News Articles [1703 Associated News Articles listed on BioPortfolio]

Horizon Discovery appoints new CEO

Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a global leader in gene editing and gene modulation technologies, is pleased to announce the appointment of Terry Piz...

Horizon Discovery shares soar as it rejects £270mln takeover approach from antibodies group Abcam

Abcam said it made a proposal to the board of Horizon Discovery on 19 April 2018 in relation to a possible all share offer which would value each Horizon share at 181p each

Horizon Discovery; Using GENESIS to create the X-MAN cell lines.

In this episode of PharmaTelevision News Review, filmed at BioTrinity 2012, Paul Larsmon talks to Darrin Disley, CEO of Horizon Discovery

AstraZeneca Joins Horizon\'s Genomics Discovery Initiative

Horizon Discovery's Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform

Horizon Discovery & AstraZeneca Collaborate on Oncology Drug Discovery Program: Chris Torrance & Tim Herpin

In this episode of PharmaTelevision News Review, filmed at BioTrinity 2013, Newbury UK, Fintan walton speaks to Chris Torrance of Horizon Discovery and Tim Herpin From AstraZeneca

Horizon Discovery rejects £270m takeover proposal from Abcam

UK-based Horizon Discovery Group has rejected a £270m offer from Abcam, saying that it is highly opportunistic and undervalues the company and its future prospects.

Horizon’s new CEO arrives amid update on takeover bid by Abcam

Horizon Discovery’s announcement on the identity of its new chief executive on Monday has been followed…

Horizon Discovery Announces Collaboration with Major Pharma Company on Single Cell RNAseq-Linked CRISPR Screening

CAMBRIDGE, England–(BUSINESS WIRE)–Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company”, or “the Group”), a global leader in gene editing an...

PubMed Articles [1553 Associated PubMed Articles listed on BioPortfolio]

Targeting miRNA for Therapeutics Using a Micronome Based Method for Identification of miRNA-mRNA Pairs and Validation of Key Regulator miRNA.

MicroRNAs are 18-22 bp long non-coding sequences and play a critical role in diverse biological processes, through modulation of gene expression at the post-transcriptional level by binding at the 3'...

MicroRNA-based therapeutics in central nervous system injuries.

Central nervous system (CNS) injuries, such as stroke, traumatic brain injury (TBI) and spinal cord injury (SCI), are important causes of death and long-term disability worldwide. MicroRNA (miRNA), sm...

Identification of microRNA Precursor-Associated Proteins.

MicroRNA (miRNA) biogenesis is regulated intricately at multiple levels. In addition to transcriptional control of pri-miRNA loci, sequence as well as structural features of the pri-miRNA-stem loop de...

Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.

Oligonucleotide therapeutics have emerged as a third distinct platform for drug discovery within the pharmaceutical industry. Five oligonucleotide-based drugs have been approved by the US FDA and over...

A critical and speculative review on microRNA technology in crop improvement: Current challenges and future directions.

MicroRNAs (miRNAs) lie at the center of gene regulation and, as such, have become novel targets for crop improvement including the enhancement of crop quality and yields as well as responses to enviro...

Clinical Trials [413 Associated Clinical Trials listed on BioPortfolio]

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

The purpose of this study is to evaluate the rhBMP-2/CRM/CD HORIZON® Spinal System as a method of facilitating spinal fusion in patients with degenerative disc disease.

HORIZON-PFT: Pivotal Fracture Trial

HORIZON-PFT (Pivotal Fracture Trial) will study the effect of zoledronic acid, given once per year, on the treatment of osteoporosis in women past menopause. Hip and vertebral fractures a...

microRNA Expression in Renal Cell Carcinoma

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look fo...

Predicting Biomarker of Gastric Cancer Chemotherapy Response

- discovery and validation of biomarker predicting gastric cancer chemotherapy response - Analysis for expression level of mRNA using Next generation sequencing in gastric ...

"Efficacy of Hybrid Systems ("Topping Off") Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study ("CD Horizon BalanC")"

Effectiveness of hybrid systems ("topping off") compared to rigid spondylodesis in fusion surgery of the lumbar spine: A prospective, randomized, bicentric pilot study ("CD HORIZON BalanC...

Companies [2342 Associated Companies listed on BioPortfolio]

Mirna Therapeutics, Inc. and Horizon Discovery Ltd.

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company focused on the development and commercialization of miRNA therapeutics. The Company has a foundational intellectual pro...

Mirna Therapeutics Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending i...

Mirna Therapeutics

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company founded in late 2007 as a spin-off from Asuragen Inc. and is located in Austin, Texas. Mirna is focused on the developm...

Horizon Therapeutics, Inc.

Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's ...

Mirna Therapeutics, Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending inte...

More Information about "Mirna Therapeutics, Inc. and Horizon Discovery Ltd." on BioPortfolio

We have published hundreds of Mirna Therapeutics, Inc. and Horizon Discovery Ltd. news stories on BioPortfolio along with dozens of Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Clinical Trials and PubMed Articles about Mirna Therapeutics, Inc. and Horizon Discovery Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Companies in our database. You can also find out about relevant Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record